Kayne Anderson Rudnick Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.38K Buy
+20
New +$3.83K ﹤0.01% 799
2026
Q1
Hold
0
939
2025
Q4
Hold
0
994
2025
Q3
Sell
-9
Closed -$1.13K 1049
2025
Q2
$1.13K Buy
+9
New +$1.12K ﹤0.01% 916
2025
Q1
Sell
-12
Closed -$1.84K 974
2024
Q4
$1.84K Buy
+12
New +$2.02K ﹤0.01% 837
2024
Q2
Sell
-3
Closed -$647 1002
2024
Q1
$647 Hold
3
﹤0.01% 891
2023
Q4
$776 Hold
3
﹤0.01% 853
2023
Q3
$771 Hold
3
﹤0.01% 762
2023
Q2
$855 Buy
+3
New +$893 ﹤0.01% 757
2022
Q3
Sell
-7
Closed -$1K 646
2022
Q2
$1K Hold
7
﹤0.01% 590
2022
Q1
$1K Sell
7
-4
-36% -$870 ﹤0.01% 620
2021
Q4
$3K Buy
11
+4
+57% +$1.03K ﹤0.01% 571
2021
Q3
$2K Hold
7
﹤0.01% 553
2021
Q2
$2K Hold
7
﹤0.01% 541
2021
Q1
$2K Hold
7
﹤0.01% 538
2020
Q4
$2K Hold
7
﹤0.01% 533
2020
Q3
$2K Hold
7
﹤0.01% 501
2020
Q2
$2K Hold
7
﹤0.01% 494
2020
Q1
$2K Hold
7
﹤0.01% 518
2019
Q4
$2K Buy
+7
New +$1.94K ﹤0.01% 549

Other funds holding BIIB

Kayne Anderson Rudnick Investment Management's BIIB Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management opened a new position in Biogen (BIIB) in Q2 2026: 20 shares worth $4.38K. The stake represents ﹤0.01% of the portfolio and ranks #799 among its holdings. This is a return to the name: Kayne Anderson Rudnick Investment Management previously reported a position in BIIB as recently as Q2 2025.

Kayne Anderson Rudnick Investment Management first reported a position in BIIB in Q4 2019 and has held it in 18 quarters since. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 20 shares of Biogen worth $4.38K as of Q2 2026.
  • Biogen was a new Kayne Anderson Rudnick Investment Management position in Q2 2026.
  • Biogen made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #799 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Biogen in Q4 2019 and has held it in 18 quarters since.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.